InvestorsHub Logo
Post# of 252864
Next 10
Followers 7
Posts 1318
Boards Moderated 0
Alias Born 04/26/2004

Re: 10nisman post# 111373

Thursday, 12/23/2010 12:05:13 PM

Thursday, December 23, 2010 12:05:13 PM

Post# of 252864
So Teva is using the FDA's complete response letter as evidence that MNTA's copaxone can not be approved without clinical trials.

Apparently, the market is buying it.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.